Skip to main content
logo
Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
28.03
-0.36 (-1.27%)
Nov 2, 2026, 10:16 AM EST - Market open

Zenas BioPharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-484.38-377.74-156.99-37.12-119.28
Depreciation & Amortization
0.030.060.140.110.08
Loss (Gain) From Sale of Assets
-0.11---
Asset Writedown & Restructuring Costs
201.67171.67-101
Loss (Gain) From Sale of Investments
-2.01-1.93-0.6--
Stock-Based Compensation
32.7326.3510.823.50.74
Other Operating Activities
23.768.21.531.0343.85
Change in Accounts Payable
-0.38-10.0411.74-0.421.09
Change in Other Net Operating Assets
2.6110.9913.69-7.626.88
Operating Cash Flow
-225.97-172.33-119.67-30.53-65.65
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-0-0.02-0.13-0.02-0.2
Sale (Purchase) of Intangibles
-65-35---2
Investment in Securities
-244.41-216.87-30.42--
Investing Cash Flow
-309.41-251.89-30.55-0.02-2.2

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Long-Term Debt Issued
---20-
Net Debt Issued (Repaid)
296.6--20-
Issuance of Common Stock
332.52152.95240.910.12-
Other Financing Activities
59.8762.34-6.33--
Financing Cash Flow
689215.28412.9620.1259.39

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
-1.04-0.250.160.08-0.04
Net Cash Flow
152.57-209.19262.89-10.35-8.5

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-225.97-172.35-119.81-30.55-65.85
Free Cash Flow Growth
-----
Free Cash Flow Margin
-22597.40%-1723.51%-2396.10%-61.09%-
Free Cash Flow Per Share
-4.22-3.85-9.08-19.95-44.13
Levered Free Cash Flow
-211.39-143.11-60.01-17.64-
Unlevered Free Cash Flow
-196.23-138.53-60.01-17.64-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Change in Working Capital
2.230.9525.43-8.047.97
SEC Filings: 10-K · 10-Q